Literature DB >> 33362478

An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors.

Chanté Muller1, Patricia H Reggio1.   

Abstract

Cannabinoids have been long studied for their therapeutic properties, particularly for their use in the treatment of pain. As new therapies are sought after to treat conditions of chronic pain, so is a better understanding of the ligands and their target receptors or channels. A recently published cryo-EM structure showed the putative binding location of a well-known cannabinoid ligand, cannabidiol (CBD), in TRPV2, a channel that has been implicated in inflammation and chronic pain. TRPV2, along with TRPV1, TRPV3, TRPV4, TRPA1, and TRPM8 all have the capability to be modulated by cannabinoid ligands and are located in the peripheral nervous system. Here, we analyze the putative CBD binding site in each of these channels and compare structural and sequential information with experimental data.
Copyright © 2020 Muller and Reggio.

Entities:  

Keywords:  TRP channels; TRPA1; TRPM8; TRPV1; TRPV2; TRPV3; TRPV4; cannabidiol

Year:  2020        PMID: 33362478      PMCID: PMC7755602          DOI: 10.3389/fncel.2020.615811

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  60 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Transient receptor potential ion channels as participants in thermosensation and thermoregulation.

Authors:  Michael J Caterina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-09-14       Impact factor: 3.619

3.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

Review 4.  Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Authors:  Gilbert Y Wong; Narender R Gavva
Journal:  Brain Res Rev       Date:  2008-12-25

Review 5.  The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target.

Authors:  Dipanjan Chanda; Dietbert Neumann; Jan F C Glatz
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-11-29       Impact factor: 4.006

6.  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Authors:  A M Malfait; R Gallily; P F Sumariwalla; A S Malik; E Andreakos; R Mechoulam; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

7.  Oral epithelial cells are activated via TRP channels.

Authors:  B Wang; A Danjo; H Kajiya; K Okabe; M A Kido
Journal:  J Dent Res       Date:  2010-12-13       Impact factor: 6.116

8.  Localization of mechanosensitive channel TRPV4 in mouse skin.

Authors:  Makoto Suzuki; Yuko Watanabe; Yuki Oyama; Atsuko Mizuno; Eiji Kusano; Atsushi Hirao; Shigeo Ookawara
Journal:  Neurosci Lett       Date:  2003-12-26       Impact factor: 3.046

9.  Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.

Authors:  F S Guimarães; J C de Aguiar; R Mechoulam; A Breuer
Journal:  Gen Pharmacol       Date:  1994-01

10.  Cannabis for chronic pain: case series and implications for clinicians.

Authors:  Mark A Ware; Ann Gamsa; Jan Persson; Mary-Ann Fitzcharles
Journal:  Pain Res Manag       Date:  2002       Impact factor: 3.037

View more
  3 in total

1.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

Review 2.  Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies.

Authors:  Fei Wang; Gabriele Multhoff
Journal:  Biomolecules       Date:  2021-04-15

3.  Vapor exposure to Δ9-tetrahydrocannabinol (THC) slows locomotion of the Maine lobster (Homarus americanus).

Authors:  Arnold Gutierrez; Kevin M Creehan; Mitchell L Turner; Rachelle N Tran; Tony M Kerr; Jacques D Nguyen; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2021-06-29       Impact factor: 3.697

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.